Colgate-Palmolive (NYSE: CL) CEO Wallace sells 45,568 shares in insider transaction

Rhea-AI Filing Summary

Colgate-Palmolive Chairman, President & CEO Noel R. Wallace reported a sale of common stock. On February 4, 2026, he sold 45,568 shares of Colgate-Palmolive common stock at a weighted average price of $93.9145 per share, in multiple transactions within a stated price range.

After this sale, Wallace directly owned 293,188 common shares. He also reported indirect ownership of 54,281 shares through the issuer's 401(k) plan trustee, 52,000 shares through a spouse trust, and 335 shares through another trust.

Insights

Insider trading and governance analyst

CEO reports planned share sale while retaining substantial direct and indirect holdings.

The filing shows Colgate-Palmolive CEO Noel R. Wallace sold 45,568 common shares on February 4, 2026 at a weighted average price of $93.9145 per share, executed across multiple trades in a narrow price range.

Following the transaction, he still directly holds 293,188 shares, plus indirect interests of 54,281 shares via the issuer’s 401(k) plan trustee, 52,000 shares via a spouse trust, and 335 shares via another trust. The form does not indicate changes to his roles as Chairman, President and CEO.

The price footnote clarifies that the sale comprised multiple executions between $93.74 and $94.17. Overall, this appears as a standard insider sale disclosure rather than a change in governance or strategy; future SEC ownership reports will provide any updated positioning.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallace Noel R.

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		S		45,568	D	$93.9145(1)	293,188	D
Common Stock								54,281	I	By Issuer's 401(k) Plan Trustee
Common Stock								52,000	I	By Spouse Trust
Common Stock								335	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.74 to $94.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Colgate-Palmolive (CL) CEO Noel R. Wallace report in this Form 4?

Noel R. Wallace reported selling 45,568 shares of Colgate-Palmolive common stock. The sale occurred on February 4, 2026 at a weighted average price of $93.9145 per share, executed in multiple trades within a narrow disclosed price range.

How many Colgate-Palmolive (CL) shares did the CEO sell and at what price?

The CEO sold 45,568 Colgate-Palmolive common shares at a weighted average price of $93.9145 per share. A footnote explains these were multiple trades between $93.74 and $94.17, and detailed trade breakdowns are available upon request.

How many Colgate-Palmolive (CL) shares does the CEO own after this transaction?

After the sale, the CEO directly owns 293,188 Colgate-Palmolive common shares. He also reports indirect ownership of 54,281 shares via the issuer’s 401(k) plan trustee, 52,000 shares through a spouse trust, and 335 shares through another trust structure.

Are there indirect Colgate-Palmolive (CL) holdings reported for the CEO in this Form 4?

Yes. The filing lists 54,281 Colgate-Palmolive shares held indirectly through the issuer’s 401(k) plan trustee, 52,000 shares held by a spouse trust, and 335 shares held by another trust, in addition to the CEO’s directly held 293,188 shares.

What does the weighted average price footnote mean in the Colgate-Palmolive (CL) Form 4?

The footnote states the reported $93.9145 price is a weighted average across multiple sales. Individual trades occurred between $93.74 and $94.17 per share, and detailed share amounts for each price are available to the issuer, shareholders, or regulators on request.